Assist. Prof. Dr. sumaira Javaid | Strutural biology | Best Researcher Award

Assist. Prof. Dr. sumaira Javaid | Strutural biology | Best Researcher Award

Assist. Prof. Dr sumaira Javaid, Dr. Panjwani Center for Molecular Medicine and Drug Research, Pakistan

Sumaira Javaid is an esteemed scientist specializing in bio-organic chemistry, molecular, and structural biology. With over eight years of post-Ph.D. experience, she has built an impactful career in academia and research. Dr. Javaid completed her Ph.D. at the H.E.J. Research Institute of Chemistry, University of Karachi, where she focused on chemical compounds with potential anti-angiogenic, antioxidant, and myelin repair properties. She furthered her studies as a post-doctoral fellow at the Institut de Pharmacologie et de Biologie Structurale (IPBS) in France. Dr. Javaid has published 17 research papers, with a combined impact factor of 77 and an h-index of 10. Her contributions to the scientific community have garnered 358 citations. As an assistant professor at the University of Karachi, she continues to guide students and conduct groundbreaking research. Her work is recognized through prestigious awards, including post-doctoral fellowships and scholarships.

Professional Profile

orcid

google scholar

Summary of Suitability for the Research for Best Researcher Award 

Dr. Sumaira Javaid is a strong candidate for the Research for Best Researcher Award. Her international exposure, innovative research, significant scholarly contributions, and mentorship abilities highlight her suitability for this award. Her work addresses critical issues in structural biology and enzyme inhibition, contributing to advancements in health and disease management, making her a well-rounded and deserving candidate.

🎓  Education 

Sumaira Javaid’s academic journey is marked by excellence in biochemistry and chemistry. She earned her Ph.D. in Chemistry from the H.E.J. Research Institute of Chemistry at the University of Karachi in 2016. Her dissertation titled “Screening of Chemical Compounds (Secondary Metabolites and Heterocyclic Synthetic Compounds) for Their Anti-Angiogenic, Anti-Oxidant, and CNS Myelin Repair Activities” demonstrated her expertise in bio-organic chemistry. Sumaira also holds an M.Sc. in Biochemistry from the University of Karachi, where she secured second position in her department. Her master’s thesis explored the behavioral effects of starvation and restricted feeding in rats. Additionally, she completed her B.Sc. (Hons) with majors in Biochemistry, Chemistry, and Microbiology from the same institution. Sumaira’s passion for research led her to pursue a post-doctoral fellowship at the Institut de Pharmacologie et de Biologie Structurale in Toulouse, France, focusing on advanced biopharmacology and structural biology from 2017 to 2018.

💼  Experience 

Sumaira Javaid brings over a decade of diverse experience in academia and research. Since September 2019, she has been an Assistant Professor at the Dr. Punjwani Center for Molecular Medicine and Drug Research, University of Karachi. She previously served as a Research Officer at the same institution and completed a one-year post-doctoral fellowship at the Institut de Pharmacologie et de Biologie Structurale (IPBS), France. Her international exposure includes a visiting scientist role at Université Paul Sabatier in Toulouse and research fellowships at renowned institutes like the National Institute for Health and Medical Research, Paris. At the H.E.J. Research Institute, University of Karachi, she was a Senior Research Fellow and later a Junior Research Fellow, contributing to advanced studies in enzyme inhibition, biochemistry, and molecular research. Sumaira has also supervised several M.Phil. and Ph.D. students, guiding their research in cancer treatment, neurobiology, and microbial enzyme inhibition.

 🏅 Awards and Honors 

Sumaira Javaid has been recognized for her outstanding contributions to research with several prestigious awards. She was awarded a Post-Doctoral Fellowship in France (2017-2018) under the Faculty Development Program, providing her the opportunity to further her studies at the Institut de Pharmacologie et de Biologie Structurale (IPBS). In 2012, she received the H.E.C. & French Embassy Split PhD and Post-Doctoral Fellowship Program award, which supported her advanced research in France and Pakistan. Throughout her academic career, Sumaira has also been acknowledged for her academic merit, having received a Merit-cum-Need Scholarship in 2005 during her undergraduate studies. Her work has been consistently recognized for its scientific impact, and she continues to be a leading figure in molecular and structural biology research. These accolades are a testament to her dedication, excellence, and influence in the field of bio-organic chemistry.

🌍  Research Focus 

Sumaira Javaid’s research focuses on bio-organic chemistry and molecular biology, with particular expertise in enzyme inhibition, biopharmaceuticals, and structural biology. Her Ph.D. research centered on exploring the anti-angiogenic, antioxidant, and myelin repair properties of secondary metabolites and synthetic compounds. She has a strong background in biomolecular NMR spectroscopy, protein purification, and enzyme inhibition assays. Sumaira’s research seeks to understand complex biochemical pathways, especially in the context of cancer treatment, neurodegenerative diseases, and infectious diseases. Her recent work has included biophysical methods to identify enzyme inhibitors that have potential therapeutic applications, particularly in treating neurological diseases and microbial infections. She has also contributed significantly to cell culturing techniques, immunohistochemistry, and immunocytochemistry. Sumaira’s collaborative projects with international institutions have expanded her research into structural biology and pharmacology, enhancing her contributions to drug discovery and molecular medicine.

 📖 Publication Top Notes

  • Title: Unexpected central role of the androgen receptor in the spontaneous regeneration of myelin

    Cited by: 122

  • Title: Zwitterionic pyrimidinium adducts as antioxidants with therapeutic potential as nitric oxide scavenger

    Cited by: 60

  • Title: Synthesis, molecular docking and xanthine oxidase inhibitory activity of 5-aryl-1H-tetrazoles

    Cited by: 35

  • Title: Synthesis and urease inhibitory activities of benzophenone semicarbazones/thiosemicarbazones

    Cited by: 27

  • Title: 2-Arylquinazolin-4(3H)-ones: A novel class of thymidine phosphorylase inhibitors

    Cited by: 16

 

Mr. Malu Daniel | Biotechnology | Research Excellence Award

Mr. Malu Daniel | Biotechnology | Research Excellence Award

Mr. Malu Daniel, University of Calabar, Calabar, Nigeria, Nigeria

MR. DANIEL GATIE MALU is a dynamic researcher with a B.Sc. in Genetics and Biotechnology from the University of Calabar, Nigeria. His expertise lies in drug design, discovery, and molecular docking, where he utilizes computational techniques such as density functional theory (DFT) to address complex scientific challenges. His passion for drug delivery systems, particularly for genetic disorders like Cystic Fibrosis and cancers, fuels his ongoing research. Throughout his academic journey, Daniel has developed strong problem-solving skills, a collaborative mindset, and a commitment to scientific integrity. He is currently involved in a research program at the University of Calabar, where he is utilizing advanced computational tools to contribute to biosensor development, biomarkers, and drug modeling. He aims to further his knowledge through a Master’s degree, focusing on theoretical and computational modeling, with a drive to innovate in pharmaceutical and chemical research.

Professional Profile

Orcid

Summary of Suitability for the Award

MR. DANIEL GATIE MALU’s academic achievements, research experience, and dedication to utilizing advanced computational methods for drug design and bio-simulation, he is a strong candidate for the ‘Research for Excellence Award.’ His contributions to multidisciplinary research and his commitment to addressing critical global health issues through innovative scientific solutions make him well-suited for this recognition. His work has the potential for significant scientific impact, aligning well with the award’s criteria for research excellence.

🎓Education 

Daniel Gatie Malu holds a B.Sc. in Genetics and Biotechnology from the University of Calabar, Nigeria, graduating in 2024. His undergraduate thesis, titled “Molecular Modeling of the Spectroscopic Structural and Bioactive Potential of Azadirachta indica against Plasmodium falciparum”, highlights his deep interest in molecular modeling and drug discovery. Daniel explored phytochemical analysis, including GCMS, HPLC, FT-IR, and UV-Vis analysis, to investigate the bioactive potential of plant compounds. His academic focus was on theoretical and experimental approaches to understanding drug interactions with biological systems, utilizing modern computational techniques. The thesis also involved evaluating stability, reactivity, and binding potential of compounds, laying a strong foundation for his future research endeavors. This academic background equipped him with a solid understanding of computational biology, molecular chemistry, and bioinformatics, and he seeks to apply this knowledge to cutting-edge research in drug design and theoretical modeling.

 💼 Experience 

MR. DANIEL GATIE MALU has a diverse research background, starting with his industrial training at Biggmade Scientific Research Academy in 2023. There, he conducted serological tests and explored bioinformatics, focusing on drug-protein interactions. He also performed DNA extraction and plant tissue culture. Since November 2023, he has been part of the Computational and Bio-Simulation Research Group at the University of Calabar, where he is immersed in full-time research. Daniel leverages advanced computational tools such as Gaussian 16, AutoDock Vina, and PyMOL to conduct molecular docking and density functional theory (DFT) studies. His interdisciplinary research spans biosensors, biomarkers, and drug delivery systems. He has also contributed to academic publications and collaborated with peers across various scientific disciplines. Daniel’s mentorship of students and his role in academic projects demonstrate his commitment to fostering intellectual growth within his community.

🏅Awards and Honors 

Daniel Gatie Malu has earned recognition for his academic excellence and contributions to scientific research. In 2024, he became a student member of the Royal Society of Chemistry, which highlights his growing prominence in the field. His work has been instrumental in several key publications and research projects, earning him respect among his peers and mentors. His interdisciplinary research, particularly in molecular docking, density functional theory (DFT), and computational modeling, has been acknowledged within the scientific community. Throughout his academic career, Daniel has demonstrated a strong commitment to advancing knowledge in the fields of biotechnology and drug design, earning him multiple awards for his research contributions at the university level. His passion for innovative solutions in drug delivery and biosensor development has also positioned him as an emerging leader in computational biology and pharmaceutical research.

🌍 Research Focus 

Daniel Gatie Malu’s research focus lies at the intersection of computational chemistry, molecular biology, and drug discovery. He employs density functional theory (DFT) and molecular docking techniques to investigate drug-target interactions, specifically for diseases like Cystic Fibrosis, Huntington’s Disease, and various cancers (BRCA1/BRCA2). Daniel is particularly interested in the design of advanced drug delivery systems such as nanoparticles and liposomes for controlled release and targeted therapies. He also explores high-throughput screening (HTS) to identify active compounds from chemical libraries, focusing on improving the pharmacokinetic and safety profiles of potential drug candidates. Additionally, Daniel investigates the absorption, distribution, metabolism, excretion, and toxicity (ADMET) properties of these compounds. His interdisciplinary research extends to biosensors and biomarkers, leveraging computational methods for innovative applications in both pharmaceuticals and environmental sciences.

📖 Publications Top Notes

How does the long G·G* Watson-Crick DNA base mispair comprising keto and enol tautomers of the guanine tautomerise? The results of a QM/QTAIM investigation.

 

Dr. Gloria Grice | Pharmacy | Best Researcher Award

Dr. Gloria Grice | Pharmacy | Best Researcher Award

Dr. Gloria Grice, University of Health Sciences and Pharmacy in St. Louis, United States

Gloria R. Grice, Pharm.D., is an accomplished academic leader and healthcare professional. She currently serves as the Associate Dean for Academic Affairs at the St. Louis College of Pharmacy, University of Health Sciences and Pharmacy in Saint Louis. With over two decades of experience in pharmacy education, Dr. Grice holds additional roles as a Professor (Non-Tenure Track) in the Department of Pharmacy Practice and a Courtesy Assistant Professor at Goldfarb School of Nursing. She earned her Doctor of Pharmacy degree from the University of Maryland, where she also completed pre-pharmacy coursework. Dr. Grice’s expertise spans pharmacotherapy, pharmacy practice, and interprofessional healthcare education. She has been recognized for her contributions to student-centered learning and ability-based education. Throughout her career, Dr. Grice has led innovative teaching and clinical practice initiatives, preparing future healthcare professionals to excel in diverse clinical settings.

Professional Profile

google scholar

Evaluation for Research for Best Researcher Award: Gloria R. Grice

Summary of Suitability
Gloria R. Grice stands out as a highly accomplished academic and healthcare professional with extensive experience in both clinical practice and academic leadership. Her tenure as Associate Dean for Academic Affairs, coupled with her long-standing role as a Professor in Pharmacy Practice, highlights her capacity for leadership, mentorship, and innovation in pharmacy education. Her rich educational background, including a Doctor of Pharmacy degree from the University of Maryland, and her specialty residency in Family Medicine, establish her as an expert in her field.

  🎓 Education 

Gloria R. Grice completed her Doctor of Pharmacy (Pharm.D.) from the University of Maryland, Baltimore, in May 2002. Prior to her Pharm.D., she pursued Pre-Pharmacy studies at the University of Maryland, College Park, from 1996 to 1998. Her academic journey was marked by an emphasis on both foundational science and clinical pharmacy practice. Dr. Grice’s education has laid the groundwork for her extensive involvement in pharmacy practice and academic leadership. Her passion for advancing pharmacy education is reflected in her current role as Associate Dean for Academic Affairs and as a Professor (Non-Tenure Track) in the Department of Pharmacy Practice. Dr. Grice continues to contribute to educational advancements by developing innovative curricula that integrate pharmacotherapy, interprofessional education, and patient-centered care approaches.

 💼 Experience

Dr. Gloria R. Grice has over two decades of experience in pharmacy practice and academia. Since July 2021, she has been the Associate Dean for Academic Affairs at the St. Louis College of Pharmacy, University of Health Sciences and Pharmacy in Saint Louis. She has also held the role of Professor (Non-Tenure Track) in the Department of Pharmacy Practice since 2015. Dr. Grice’s teaching career includes serving as a course coordinator, lecturer, and preceptor for numerous pharmacy and interprofessional education courses. Her earlier roles include Clinical Instructor and Clerkship Preceptor, where she provided experiential education in primary care and geriatrics. Dr. Grice’s residency at St. John’s Mercy Family Medicine expanded her clinical practice in various specialties, including internal medicine and geriatrics. Her clinical and educational expertise continues to shape the next generation of pharmacists and healthcare professionals.

  🏅Awards and Honors 

Dr. Gloria R. Grice has received several recognitions for her contributions to pharmacy education and clinical practice. She holds certifications in Advanced Cardiac Life Support (ACLS) and Immunization from the American Pharmacists Association, demonstrating her clinical proficiency. Additionally, she has been a Board Certified Pharmacotherapy Specialist since 2003, further renewed in 2010 and 2017, underscoring her expertise in pharmacotherapy. Dr. Grice is also licensed to practice pharmacy in both Missouri and Maryland. Throughout her career, she has been honored for her commitment to student-centered, ability-based education, particularly in the areas of primary care and interprofessional healthcare education. Her role in shaping experiential learning and preceptorship has earned her significant respect among peers and students alike. Dr. Grice’s leadership in academic administration further exemplifies her dedication to advancing the field of pharmacy education.

  🌍 Research Focus 

Dr. Gloria R. Grice’s research focuses on interprofessional education, pharmacotherapy, and innovative approaches to healthcare education. She is particularly interested in how collaborative, patient-centered care can be enhanced through better integration of pharmacists into interprofessional healthcare teams. Her work explores the role of pharmacy in managing chronic conditions such as diabetes, hypertension, and heart failure, as well as the optimization of pharmacogenomics in primary care settings. Dr. Grice has contributed to research on educational strategies, including ability-based learning and assessment-driven methodologies. Her goal is to advance the quality of pharmacy education, preparing healthcare professionals to deliver comprehensive, team-based care. Dr. Grice’s research also highlights the importance of experiential learning and preceptorship in cultivating future leaders in pharmacy practice.

  📖 Publications Top Notes

Use of pharmacogenetic and clinical factors to predict the therapeutic dose of warfarin
  • Citations: 998
Integration of genetic, clinical, and INR data to refine warfarin dosing
  • Citations: 267
Genetic-based dosing in orthopedic patients beginning warfarin therapy
  • Citations: 225
A polymorphism in the VKORC1 regulator calumenin predicts higher warfarin dose
  • Citations: 126
Laboratory and clinical outcomes of pharmacogenetic vs. clinical protocols for warfarin initiation in orthopedic patients
  • Citations: 100